Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...

The Food and Drug Administration is considering revoking Pfizer Inc.’s authorization to sell its Covid vaccine for children under the age of 5, a move that would leave healthy kids with no available ...

This fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID.

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...

A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...

Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...

Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that $500 million ...

“Stratus,” originally known as Variant XFG, is the second most prominent strain of COVID in the United States. According to ...

So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel ...

These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...